Updates are available Correction dated 2024-03-26

Article History

Received: 10 September 2021

Accepted: 1 November 2021

First Online: 18 November 2021

Change Date: 26 March 2024

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s00405-024-08521-3

Declaration

:

: Rauch AK—MED-EL, Innsbruck, Österreich: reimbursement of travel expenses. Wesarg T—Cochlear Deutschland GmbH & Co. KG, Germany: research funding, reimbursement of travel expenses; MED-EL Deutschland GmbH, Germany: research funding, reimbursement of travel expenses; Advanced Bionics AG, Stäfa, Switzerland: non-financial support, research funding, reimbursement of travel expenses. Aschendorff A—Cochlear Ltd., Lane Cove, Australia: research funding, reimbursement of travel expenses; MED-EL, Innsbruck, Österreich: research funding, reimbursement of travel expenses; Advanced Bionics, Stäfa, Schweiz: research funding, reimbursement of travel expenses; Oticon Medical A/S, Smørum, Dänemark: research funding, reimbursement of travel expenses. Speck I – Cochlear Ltd., Lane Cove, Australia: reimbursement of travel expenses. Arndt S – Cochlear Ltd., Lane Cove, Australia: research funding, reimbursement of travel expenses; MED-EL, Innsbruck, Österreich: research funding, reimbursement of travel expenses; Advanced Bionics, Stäfa, Schweiz: research funding, reimbursement of travel expenses; Oticon Medical A/S, Smørum, Dänemark: research funding, reimbursement of travel expenses.

: Our study was approved by the local ethics committee (No. 21-1142) and done in agreement with the Declaration of Helsinki (2013 version). Informed consent was obtained by all participating students prior to the study. This study was registered with DRKS (; No. DRKS00024640).